Invention Grant
- Patent Title: Vitronectin:keratinocyte growth factor chimeras
- Patent Title (中): Vitronectin:角质形成细胞生长因子嵌合体
-
Application No.: US13701472Application Date: 2011-06-03
-
Publication No.: US09562086B2Publication Date: 2017-02-07
- Inventor: Zee Upton
- Applicant: Zee Upton
- Applicant Address: AU Brisbane
- Assignee: QUEENSLAND UNIVERSITY OF TECHNOLOGY
- Current Assignee: QUEENSLAND UNIVERSITY OF TECHNOLOGY
- Current Assignee Address: AU Brisbane
- Agency: Faegre Baker Daniels LLP
- International Application: PCT/AU2011/000700 WO 20110603
- International Announcement: WO2011/150470 WO 20111208
- Main IPC: C07K14/50
- IPC: C07K14/50 ; C07K14/475 ; C07K14/435 ; C07K16/28 ; A61K38/00

Abstract:
Isolated protein complexes are provided comprising keratinocyte growth factor and vitronectin, or at least domains thereof that enable binding to and activation of both a keratinocyte growth factor receptor and an integrin receptor for vitronectin. These protein complexes include synthetic proteins where the keratinocyte growth factor and vitronectin sequences are joined by a linker sequence. In particular forms, vitronectin sequences do not include a C-terminal heparin binding domain. Also provided are uses of these protein complexes for stimulating or inducing cell migration and/or proliferation in wound healing, tissue engineering, cosmetic and therapeutic treatments such as skin replacement, skin replenishment and treatment of burns where epithelial cell migration is required. In other embodiments, the invention provides inhibition of cancer cell metastasis, particularly in relation to breast cancer.
Public/Granted literature
- US20130243843A1 Vitronectin:Keratinocyte Growth Factor Chimeras Public/Granted day:2013-09-19
Information query